Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome

50Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Activating mutations in the genes encoding the ATP-sensitive potassium (KATP) channel subunits Kir6.2 and SUR1 are a common cause of neonatal diabetes. Here, we analyse the molecular mechanism of action of the heterozygous mutation F132L, which lies in the first set of transmembrane helices (TMD0) of SUR1. This mutation causes severe developmental delay, epilepsy and permanent neonatal diabetes (DEND syndrome). We show that the F132L mutation reduces the ATP sensitivity of KATP channels indirectly, by altering the intrinsic gating of the channel. Thus, the open probability is markedly increased when Kir6.2 is co-expressed with mutant TMD0 alone or with mutant SUR1. The F132L mutation disrupts the physical interaction between Kir6.2 and TMD0, but does not alter the plasmalemma channel density. Our results explain how a mutation in an accessory subunit can produce enhanced activity of the KATP channel pore (formed by Kir6.2). They also provide further evidence that interactions between TMD0 of SUR1 and Kir6.2 are critical for KATP channel gating and identify a residue crucial for this interaction at both physical and functional levels. © The Author 2007. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Proks, P., Shimomura, K., Craig, T. J., Girard, C. A. J., & Ashcroft, F. M. (2007). Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome. Human Molecular Genetics, 16(16), 2011–2019. https://doi.org/10.1093/hmg/ddm149

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free